Project Grant HT94252410816
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$2.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,477,500 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The 3-year grant, awarded on September 1, 2023, will fund research on "Topical Calcitonin Gene-Related Peptide for Corneal Injury Prevention and Regeneration." The Schepens Eye Research Institute, which has...
The Schepens Eye Research Institute, Inc. was awarded a $1,475,676 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop concomitant topical treatments for pain and inflammation resulting from ocular injuries. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
The Department of the Army Medical Command awarded a $1,428,860 Project Grant to The Schepens Eye Research Institute, Inc. of Boston, MA under the Military Medical Research and Development program (CFDA 12.420) to investigate the safety and efficacy of supersaturated oxygen emulsion (SSOE) as a novel topical treatment for open globe injury. The three-year award beginning September 30, 2022 will support animal research using mice to test SSOE and controls supplied by sub-awardee Coruna Medical...
The Department of the Army Medical Command awarded a $2.13 million Project Grant to Palo Alto Veterans Institute For Research (doing business as Pavir) to develop a photoactivated regenerative collagen sealant for rapid vision restoration after deep corneal injuries. The period of performance for this award is from September 1, 2022 through August 31, 2025. The award is being made under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and...
The Defense Health Agency awarded a $1,061,440 Project Grant to the University of South Florida (USF) on September 1, 2023 under the Military Medical Research and Development (CFDA 12.420) program. This 3-year grant will support USF's development of an artificial cornea and sensor-based continuous intraocular pressure (IOP) monitoring system to treat patients with cornea blindness secondary to war-related ocular injuries. The products and services to be delivered through this grant include...
This $1,622,955 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research and development of a novel therapeutic agent called LACRIPEP for corneal wound healing and ocular surface homeostasis. The grant was awarded on September 15, 2024 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit research organization, with a performance period ending on September 14,...
This $543,037 federal Project Grant award, issued by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the Drosophila corneal lens model. The research aims to: 1) identify transcription factors and chromatin changes regulating the differentiation of cone and pigment cells that secrete the corneal lens; 2) examine how the timing of cone and pigment cell...
The National Eye Institute (NEI) awarded a $412,285 Project Grant under the Vision Research program (CFDA 93.867) to Oregon Health & Science University (OHSU) to validate an advanced transepithelial corneal collagen crosslinking (CXL) technology. The goal is to develop a more effective CXL procedure that can strengthen the cornea without requiring removal of the surface epithelium, which often leads to complications. The key products and services to be delivered include: Constructing an...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...